Skip to main content
Clinical Trials/TCTR20210326008
TCTR20210326008
Completed
Phase 4

The Effect of Preoperative Submucosal Administration of Dexamethasone Tramadol Articaine on The Success Rate of Inferior Alveolar Nerve Block on Mandibular Molars With Symptomatic Irreversible Pulpitis A Randomized Double Blind Placebo Controlled Clinical Trial

/A0 sites120 target enrollmentMarch 26, 2021

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
It is difficult to provide complete pulpal anesthesia in mandibular molars with irreversible pulpitis. To establish the effects of submucosal tramadol, dexamethasone, articaine on the success of inferior alveolar nerve block in the endodontic treatment of mandibular molars with symptomatic irreversible pulpitis.
Sponsor
/A
Enrollment
120
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 26, 2021
End Date
September 25, 2020
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • The inclusion criteria included systemically healthy patients, aged between 18 and 65 years, having mandibular molars with symptomatic irreversible pulpitis, preoperative pain score ranging from moderate to severe on a Heft\-Parker visual analog scale, radiographically normal periapical area and no pain on percussion.

Exclusion Criteria

  • The exclusion criteria comprised: pregnant or breastfeeding women, patients with allergy, sensitivity or adverse reactions to the medications administered in this study, those who had taken an analgesic or anti\-inflammatory drug within last 12 hours before the treatment, those with unrestorable teeth, teeth with periodontal disease, root resorption, open apex, calcified root canals and pulpal necrosis.

Outcomes

Primary Outcomes

Not specified

Similar Trials